Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2009

Open Access 01-12-2009 | Research article

Prevention of type 2 diabetes in adults with impaired glucose tolerance: the European Diabetes Prevention RCT in Newcastle upon Tyne, UK

Authors: Linda Penn, Martin White, John Oldroyd, Mark Walker, K George MM Alberti, John C Mathers

Published in: BMC Public Health | Issue 1/2009

Login to get access

Abstract

Background

Diabetes prevalence is increasing. The Finnish Diabetes Prevention Study (DPS) showed a 58% reduction in Type 2 Diabetes (T2D) incidence in adults with impaired glucose tolerance (IGT). The European Diabetes Prevention Study (EDIPS) extends the DPS to different European populations, using the same study design. In the Newcastle arm of this study (EDIPS-Newcastle), we tested the hypothesis that T2D can be prevented by lifestyle intervention and explored secondary outcomes in relation to diabetes incidence.

Methods

We recruited 102 participants (42 men and 60 women, mean age 57 years, mean BMI 34 kgm-2) with IGT to EDIPS-Newcastle and randomised to Intervention and usual care Control groups. The intervention included individual motivational interviewing aimed at: weight reduction, increase in physical activity, fibre and carbohydrate intake and reduction of fat intake (secondary outcomes). The primary outcome was diagnosis of T2D.

Results

Mean duration of follow-up was 3.1 years. T2D was diagnosed in 16 participants (I = 5, C = 11). Absolute incidence of T2D was 32.7 per 1000 person-years in the Intervention-group and 67.1 per 1000 person-years in the Control-group. The overall incidence of diabetes was reduced by 55% in the Intervention-group, compared with the Control-group: RR 0.45 (95%CI 0.2 to 1.2).
Explanatory survival analysis of secondary outcomes showed that those who sustained beneficial changes for two or more years reduced their risk of developing T2D.

Conclusion

Our results are consistent with other diabetes prevention trials. This study was designed as part of a larger study and although the sample size limits statistical significance, the results contribute to the evidence that T2D can be prevented by lifestyle changes in adults with IGT. In explanatory analysis small sustained beneficial changes in weight, physical activity or dietary factors were associated with reduction in T2D incidence.

Trial Registration

International Standard Randomised Controlled Trial Number registry (ISRCTN)
Registry number: ISRCTN 15670600
http://​www.​controlled-trials.​com/​isrctn/​search.​html?​srch=​15670600%26sort=​3%26dir=​desc%26max=​10
Appendix
Available only for authorised users
Literature
1.
International Diabetes Federation: Diabetes Atlas. 2006, Brussels: International Diabetes Federation, 3
2.
Roberts S: Improving Diabetes Services, the National Service Framework for Diabetes two years on. 2005, Edited by Health Do. London: TSO
3.
Saad MF, Knowler WC, Pettit DJ, Nelson RG, MA C, et al: A two step model for the development of non-insulin dependent diabetes mellitus. American Journal of Medicine. 1991, 90: 229-235.CrossRefPubMed
4.
Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT, Khunti K: Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ. 2007, 334 (7588): 299-10.1136/bmj.39063.689375.55.CrossRefPubMedPubMedCentral
5.
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine. 2002, 346 (6): 393-403. 10.1056/NEJMoa012512.CrossRefPubMed
6.
Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, et al: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997, 20 (4): 537-544. 10.2337/diacare.20.4.537.CrossRefPubMed
7.
Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V, for the Indian Diabetes Prevention Programme: The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006, 49 (2): 289-297. 10.1007/s00125-005-0097-z.CrossRefPubMed
8.
Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, et al: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New England Journal of Medicine. 2001, 344 (18): 1343-1350. 10.1056/NEJM200105033441801.CrossRefPubMed
9.
Eriksson J, Lindstrom J, Valle T, Aunola S, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Lauhkonen M, Lehto P, et al: Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme. Diabetologia. 1999, 42 (7): 793-801. 10.1007/s001250051229.CrossRefPubMed
10.
Mensink M, Corpeleijn E, Feskens EJM, Kruijshoop M, Saris WHM, de Bruin TWA, Blaak EE: Study on lifestyle-intervention and impaired glucose tolerance Maastricht (SLIM): design and screening results. Diabetes Research & Clinical Practice. 2003, 61 (1): 49-58. 10.1016/S0168-8227(03)00067-6.CrossRef
11.
WHO Study Group on Diabetes Mellitus: WHO Technical Report Series. 1985, Geneva: WHO, 727:
12.
Hays RD, Sherbourne CD, Mazel RM: The RAND 36-Item Health Survey 1.0[see comment]. Health Economics. 1993, 2 (3): 217-227. 10.1002/hec.4730020305.CrossRefPubMed
13.
Rose GABH, Gillum RF, Prineas RJ: Cardiovascular Survey Methods. Monograph series No 56. 1982, Geneva: World Health Organization, 2
14.
Nelson MAM, Meyer J: Food Portion Sizes. 1997, London: MAFF
15.
Rollnick S, Mason P, Butler C: Health Behaviour Change. 1999, Edinburgh: Churchill livingstone
16.
Ha TK, Lean ME: Recommendations for the nutritional management of patients with diabetes mellitus. European Journal of Clinical Nutrition. 1998, 52 (7): 467-481. 10.1038/sj.ejcn.1600599.CrossRefPubMed
17.
Oldroyd JC, Unwin NC, White M, Mathers JC, Alberti KGMM: Randomised controlled trial evaluating lifestyle interventions in people with impaired glucose tolerance. Diabetes Research and Clinical Practice. 2006, 72: 117-127. 10.1016/j.diabres.2005.09.018.CrossRefPubMed
18.
Harland J, White M, Drinkwater C, Chinn D, Farr L, Howel D: The Newcastle exercise project: a randomised controlled trial of methods to promote physical activity in primary care. BMJ. 1999, 319 (7213): 828-832.CrossRefPubMedPubMedCentral
19.
Oldroyd JC, Unwin NC, White M, Imrie K, Mathers JC, Alberti KGMM: Randomised controlled trial evaluating the effectiveness of behavioural interventions to modify cardiovascular risk factors in men and women with impaired glucose tolerance: outcomes at 6 months. Diabetes Research and Clinical Practice. 2001, 52 (1): 29-43. 10.1016/S0168-8227(00)00244-8.CrossRefPubMed
20.
Penn L, Moffatt SM, White M: Participants' perspective on maintaining behaviour change: a qualitative study within the European Diabetes Prevention Study. BMC Public Health. 2008, 8: 235-10.1186/1471-2458-8-235.CrossRefPubMedPubMedCentral
21.
Lindstrom J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, Uusitupa M, Tuomilehto J, for the Finnish Diabetes Prevention Study Group: The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care. 2003, 26 (12): 3230-3236. 10.2337/diacare.26.12.3230.CrossRefPubMed
22.
Lindstrom J, Tuomilehto J: The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care. 2003, 26 (3): 725-731. 10.2337/diacare.26.3.725.CrossRefPubMed
23.
Schwarz PEH, Lindstrom J, Kissimova-Scarbeck K, Szybinski Z, Barengo NC, Peltonen M, Tuomilehto J, project D-P: The European perspective of type 2 diabetes prevention: diabetes in Europe--prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project. Experimental & Clinical Endocrinology & Diabetes. 2008, 116 (3): 167-172. 10.1055/s-2007-992115.CrossRef
24.
Black C: Working for a healthier tomorrow: Dame Carol Black's review of the health of Britain's working age population. 2008, Edited by health Do. London: TSO
25.
Schwarz PEH, Schwarz J, Schuppenies A, Bornstein SR, Schulze J: Development of a diabetes prevention management program for clinical practice. Public Health Reports. 2007, 122 (2): 258-263.PubMedPubMedCentral
26.
Schwarz PEH, Gruhl U, Bornstein SR, Landgraf R, Hall M, Tuomilehto J: The European Perspective on Diabetes Prevention: Development and Implementation of A European Guideline and training standards for diabetes prevention (IMAGE). Diabetes and Vascular Disease Research. 2007, 4 (4): 353-357. 10.3132/dvdr.2007.064.CrossRefPubMed
Metadata
Title
Prevention of type 2 diabetes in adults with impaired glucose tolerance: the European Diabetes Prevention RCT in Newcastle upon Tyne, UK
Authors
Linda Penn
Martin White
John Oldroyd
Mark Walker
K George MM Alberti
John C Mathers
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2009
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-9-342

Other articles of this Issue 1/2009

BMC Public Health 1/2009 Go to the issue

Research article

Cost of dengue and other febrile illnesses to households in rural Cambodia: a prospective community-based case-control study

Debate

Are we losing the battle against cardiometabolic disease? The case for a paradigm shift in primary prevention

Study protocol

Feasibility, design and conduct of a pragmatic randomized controlled trial to reduce overweight and obesity in children: The electronic games to aid motivation to exercise (eGAME) study

Study protocol

The effectiveness of a training for patients with unexplained physical symptoms: protocol of a cognitive behavioral group training and randomized controlled trial

Research article

Phone and e-mail counselling are effective for weight management in an overweight working population: a randomized controlled trial

Research article

Adolescent's perceptions and expectations of parental action on children's smoking and snus use; national cross sectional data from three decades